Lu Shui-Rong, Li Qin, Lu Jin-Lai, Liu Chongni, Xu Xiaohong, Li Jing-Ze
Department of Gastroenterology, Shanghai East Hospital, Tongji University, Shanghai 200123, P.R. China.
Department of Gastroenterology, Xianyang Central Hospital, Xianyang, Shaanxi 712000, P.R. China.
Exp Ther Med. 2018 Dec;16(6):4879-4885. doi: 10.3892/etm.2018.6775. Epub 2018 Sep 19.
Increasing evidence indicates that long non-coding RNAs (lncRNAs) are closely associated with the progression of human cancer, including colorectal cancer (CRC). A previous study suggested that lncRNA LINC01503 promotes squamous cell carcinoma progression. However, the function of LINC01503 in CRC has remained elusive. The present study indicated that LINC01503 was significantly upregulated in CRC tissues compared with that in adjacent normal tissues as detected by reverse transcription-quantitative polymerase chain reaction. It was demonstrated that knockdown of long intergenic non-protein coding RNA (LINC)01503 markedly inhibited the proliferation and invasion of CRC cells, whereas overexpression of LINC01503 had the opposite effects, as indicated by Cell Counting kit-8 and Transwell assays. Mechanistically, it was revealed that LINC01503 serves as a sponge for microRNA (miR)-4492, which targets forkhead box K1 (FOXK1) in CRC cells. In addition, luciferase reporter assays demonstrated the direct binding of miR-4492 mimics to LINC01503 and to a sequence in the 3'-untranslated region of FOXK1. Furthermore, it was demonstrated that overexpression of LINC01503 reduced the availability of miR-4492 in CRC cells. Furthermore, miR-4492 mimics inhibited FOXK1 expression, while simultaneous overexpression of LINC01503 abolished this effect. Finally, it was demonstrated that restoration of FOXK1 abolished the inhibitory effect of LINC01503 knockdown on CRC cell proliferation and invasion. Taken together, the present results suggested that LINC01503 promotes CRC progression via acting as a competing endogenous RNA for miR-4492/FOXK1.
越来越多的证据表明,长链非编码RNA(lncRNA)与包括结直肠癌(CRC)在内的人类癌症进展密切相关。先前的一项研究表明,lncRNA LINC01503促进鳞状细胞癌进展。然而,LINC01503在CRC中的功能仍不清楚。本研究表明,通过逆转录-定量聚合酶链反应检测,与相邻正常组织相比,LINC01503在CRC组织中显著上调。细胞计数试剂盒-8和Transwell实验表明,长链基因间非编码RNA(LINC)01503的敲低显著抑制了CRC细胞的增殖和侵袭,而LINC01503的过表达则产生相反的效果。机制上,研究发现LINC01503作为微小RNA(miR)-4492的海绵,在CRC细胞中靶向叉头框K1(FOXK1)。此外,荧光素酶报告基因实验证明了miR-4492模拟物与LINC01503以及与FOXK1 3'-非翻译区中的序列直接结合。此外,研究表明LINC01503的过表达降低了CRC细胞中miR-4492的可用性。此外,miR-4492模拟物抑制FOXK1表达,而LINC01503的同时过表达消除了这种作用。最后,研究表明FOXK1的恢复消除了LINC01503敲低对CRC细胞增殖和侵袭的抑制作用。综上所述,目前的结果表明,LINC01503通过作为miR-4492/FOXK1的竞争性内源性RNA促进CRC进展。